Aevitas Wealth Management, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aevitas Wealth Management, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$219,000
-51.2%
1,850
-44.8%
0.13%
-54.5%
Q3 2021$449,000
-26.0%
3,350
-10.7%
0.29%
-26.3%
Q2 2021$607,000
+101.7%
3,7500.0%0.39%
+84.8%
Q1 2021$301,000
+47.5%
3,7500.0%0.21%
+40.9%
Q4 2020$204,000
+1754.5%
3,750
+435.7%
0.15%
+1390.0%
Q1 2019$11,000
+10.0%
7000.0%0.01%0.0%
Q4 2018$10,000
-50.0%
7000.0%0.01%
-44.4%
Q3 2018$20,000
+5.3%
7000.0%0.02%0.0%
Q2 2018$19,000
+26.7%
7000.0%0.02%
+20.0%
Q1 2018$15,000
+15.4%
7000.0%0.02%
+25.0%
Q4 2017$13,0007000.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders